Monkeypox: Europe, US worst hit; account for 95% of recognized circumstances, says WHO | World News

Europe and the Americas have been affected essentially the most by the monkeypox outbreak, Director Normal of the World Well being Group (WHO) Tedros Adhanom Ghebreyesus instructed journalists right here on Wednesday.

ALSO READ | India isolates monkeypox virus, first step to vaccines

These two areas have reported 95 per cent of the recognized circumstances, he stated, warning towards stigma and discrimination in monkeypox messaging.

Over 18,000 monkeypox circumstances have been reported to the WHO from 78 international locations. Greater than 70 per cent of those got here from the European area and 25 per cent from the Americas, he stated.

He stated that 98 per cent of the reported circumstances have been amongst males who've intercourse with males, stressing that stigma and discrimination will be "as harmful as any virus and may gas the outbreak."

"As now we have seen with COVID-19 misinformation," it might unfold quickly on-line, he stated, "so we name on social media platforms, tech firms and information organizations to work with us to stop and counter dangerous info."

Final Saturday, the WHO formally declared monkeypox a public well being emergency of worldwide concern (PHEIC). A PHEIC is the very best stage of alert that the United Nations (UN) well being physique may give.

The WHO has been urging international locations to take the monkeypox outbreak significantly by taking the steps wanted to cease transmission and shield weak teams. "One of the simplest ways to try this is to cut back the chance of publicity and make secure decisions," he stated.

"For males who've intercourse with males, this contains, for the second, decreasing your variety of sexual companions, reconsidering intercourse with new companions, and exchanging contact particulars with any new companions to allow follow-up if wanted."

In the meantime, Canada, the European Union and the US have already accepted the vaccine known as MVA-BN (Modified Vaccinia Ankara - Bavarian Nordic) to be used towards monkeypox, and two different vaccines are additionally being assessed. Nonetheless, because of the lack of knowledge on the effectiveness and dosage of the vaccines, the WHO at the moment doesn't advocate mass vaccination towards monkeypox. It additionally urges all international locations which might be administering such vaccines to gather and share essential knowledge on their effectiveness.

ANI/Xinhua